BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Islam T, Rahman MR, Aydin B, Beklen H, Arga KY, Shahjaman M. Integrative transcriptomics analysis of lung epithelial cells and identification of repurposable drug candidates for COVID-19. Eur J Pharmacol 2020;887:173594. [PMID: 32971089 DOI: 10.1016/j.ejphar.2020.173594] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhang H, Feng T. Network-Based Data Analysis Reveals Ion Channel-Related Gene Features in COVID-19: A Bioinformatic Approach. Biochem Genet. [DOI: 10.1007/s10528-022-10280-x] [Reference Citation Analysis]
2 Chakraborty S, Mallick D, Goswami M, Guengerich FP, Chakrabarty A, Chowdhury G. The Natural Products Withaferin A and Withanone from the Medicinal Herb Withania somnifera Are Covalent Inhibitors of the SARS-CoV-2 Main Protease. J Nat Prod 2022. [PMID: 36098617 DOI: 10.1021/acs.jnatprod.2c00521] [Reference Citation Analysis]
3 Lu L, Liu L, Gui R, Dong H, Su Y, Zhou X, Liu F. Discovering common pathogenetic processes between COVID-19 and sepsis by bioinformatics and system biology approach. Front Immunol 2022;13:975848. [DOI: 10.3389/fimmu.2022.975848] [Reference Citation Analysis]
4 Al-Mustanjid M, Mahmud SH, Akter F, Rahman MS, Hossen MS, Rahman MH, Moni MA. Systems biology models to identify the influence of SARS-CoV-2 infections to the progression of human autoimmune diseases. Inform Med Unlocked 2022;:101003. [PMID: 35818398 DOI: 10.1016/j.imu.2022.101003] [Reference Citation Analysis]
5 Che L, Chen G, Cai X, Xie Z, Xia T, Zhang W, Liu S. Bioinformatics Approach Predicts Candidate Targets for SARS-CoV-2 Infections to COPD Patients. Biomed Res Int 2022;2022:1806427. [PMID: 35747501 DOI: 10.1155/2022/1806427] [Reference Citation Analysis]
6 Mosharaf MP, Reza MS, Gov E, Mahumud RA, Mollah MNH. Disclosing Potential Key Genes, Therapeutic Targets and Agents for Non-Small Cell Lung Cancer: Evidence from Integrative Bioinformatics Analysis. Vaccines 2022;10:771. [DOI: 10.3390/vaccines10050771] [Reference Citation Analysis]
7 Bhartiya P, Lim JS, Kaushik N, Shaik AM, Shin YO, Kaushik NK, Choi EH. Nonthermal plasma‐generated ozone inhibits human coronavirus 229E infectivity on glass surface. Plasma Processes & Polymers. [DOI: 10.1002/ppap.202200054] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Qu N, Hui Z, Shen Z, Kan C, Hou N, Sun X, Han F. Thyroid Cancer and COVID-19: Prospects for Therapeutic Approaches and Drug Development. Front Endocrinol 2022;13:873027. [DOI: 10.3389/fendo.2022.873027] [Reference Citation Analysis]
9 Ahmed FF, Reza MS, Sarker MS, Islam MS, Mosharaf MP, Hasan S, Mollah MNH. Identification of host transcriptome-guided repurposable drugs for SARS-CoV-1 infections and their validation with SARS-CoV-2 infections by using the integrated bioinformatics approaches. PLoS One 2022;17:e0266124. [PMID: 35390032 DOI: 10.1371/journal.pone.0266124] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Mosharaf MP, Reza MS, Kibria MK, Ahmed FF, Kabir MH, Hasan S, Mollah MNH. Computational identification of host genomic biomarkers highlighting their functions, pathways and regulators that influence SARS-CoV-2 infections and drug repurposing. Sci Rep 2022;12:4279. [PMID: 35277538 DOI: 10.1038/s41598-022-08073-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
11 Aydin B, Yildirim E, Erdogan O, Arga KY, Yilmaz BK, Bozkurt SU, Bayrakli F, Turanli B. Past, Present, and Future of Therapies for Pituitary Neuroendocrine Tumors: Need for Omics and Drug Repositioning Guidance. OMICS 2022;26:115-29. [PMID: 35172108 DOI: 10.1089/omi.2021.0221] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Hasankhani A, Bahrami A, Sheybani N, Aria B, Hemati B, Fatehi F, Ghaem Maghami Farahani H, Javanmard G, Rezaee M, Kastelic JP, Barkema HW. Differential Co-Expression Network Analysis Reveals Key Hub-High Traffic Genes as Potential Therapeutic Targets for COVID-19 Pandemic. Front Immunol 2021;12:789317. [PMID: 34975885 DOI: 10.3389/fimmu.2021.789317] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
13 Su C, Rousseau S, Emad A. Identification of transcriptional regulatory network associated with response of host epithelial cells to SARS-CoV-2. Sci Rep 2021;11:23928. [PMID: 34907210 DOI: 10.1038/s41598-021-03309-5] [Reference Citation Analysis]
14 Imami AS, McCullumsmith RE, O'Donovan SM. Strategies to identify candidate repurposable drugs: COVID-19 treatment as a case example. Transl Psychiatry 2021;11:591. [PMID: 34785660 DOI: 10.1038/s41398-021-01724-w] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Shahjaman M, Rahman MR, Islam T, Auwul MR, Moni MA, Mollah MNH. rMisbeta: A robust missing value imputation approach in transcriptomics and metabolomics data. Comput Biol Med 2021;138:104911. [PMID: 34634637 DOI: 10.1016/j.compbiomed.2021.104911] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Shahjaman M, Rezanur Rahman M, Rabiul Auwul M. A network-based systems biology approach for identification of shared Gene signatures between male and female in COVID-19 datasets. Inform Med Unlocked 2021;25:100702. [PMID: 34423108 DOI: 10.1016/j.imu.2021.100702] [Reference Citation Analysis]
17 Qiu H, Zhang X, Yu H, Gao R, Shi J, Shen T. Identification of potential targets of triptolide in regulating the tumor microenvironment of stomach adenocarcinoma patients using bioinformatics. Bioengineered 2021;12:4304-19. [PMID: 34348580 DOI: 10.1080/21655979.2021.1945522] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Zhao H, Zhang Q, Chen H, Rezanur Rahman M, Md Faruquee H. Integrated multi-omics approach identified molecular mechanism and pathogenetic processes of COVID-19 that affect patient with Parkinson's disorder. Saudi J Biol Sci 2021. [PMID: 34366686 DOI: 10.1016/j.sjbs.2021.07.074] [Reference Citation Analysis]
19 Rahman MR, Islam T, Shahjaman M, Islam MR, Lombardo SD, Bramanti P, Ciurleo R, Bramanti A, Tchorbanov A, Fisicaro F, Fagone P, Nicoletti F, Pennisi M. Discovering common pathogenetic processes between COVID-19 and diabetes mellitus by differential gene expression pattern analysis. Brief Bioinform 2021:bbab262. [PMID: 34260684 DOI: 10.1093/bib/bbab262] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
20 de Melo GD, Lazarini F, Larrous F, Feige L, Kornobis E, Levallois S, Marchio A, Kergoat L, Hardy D, Cokelaer T, Pineau P, Lecuit M, Lledo PM, Changeux JP, Bourhy H. Attenuation of clinical and immunological outcomes during SARS-CoV-2 infection by ivermectin. EMBO Mol Med 2021;13:e14122. [PMID: 34170074 DOI: 10.15252/emmm.202114122] [Cited by in F6Publishing: 12] [Reference Citation Analysis]
21 Rabiul Auwul M, Zhang C, Rezanur Rahman M, Shahjaman M, Alyami SA, Ali Moni M. Network-Based Transcriptomic Analysis Identifies the Genetic Effect of COVID-19 to Chronic Kidney Disease Patients: A Bioinformatics Approach. Saudi J Biol Sci 2021. [PMID: 34127904 DOI: 10.1016/j.sjbs.2021.06.015] [Reference Citation Analysis]
22 Zheng W, Huang X, Lai Y, Liu X, Jiang Y, Zhan S. Glycyrrhizic Acid for COVID-19: Findings of Targeting Pivotal Inflammatory Pathways Triggered by SARS-CoV-2. Front Pharmacol 2021;12:631206. [PMID: 34177566 DOI: 10.3389/fphar.2021.631206] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
23 Wu M, Zhang Y, Grosser M, Tipper S, Venter D, Lin H, Lu J. Profiling COVID-19 Genetic Research: A Data-Driven Study Utilizing Intelligent Bibliometrics. Front Res Metr Anal 2021;6:683212. [PMID: 34109284 DOI: 10.3389/frma.2021.683212] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
24 Auwul MR, Rahman MR, Gov E, Shahjaman M, Moni MA. Bioinformatics and machine learning approach identifies potential drug targets and pathways in COVID-19. Brief Bioinform 2021:bbab120. [PMID: 33839760 DOI: 10.1093/bib/bbab120] [Cited by in F6Publishing: 22] [Reference Citation Analysis]
25 Hartog N, Faber W, Frisch A, Bauss J, Bupp CP, Rajasekaran S, Prokop JW. SARS-CoV-2 infection: molecular mechanisms of severe outcomes to suggest therapeutics. Expert Rev Proteomics 2021;18:105-18. [PMID: 33779460 DOI: 10.1080/14789450.2021.1908894] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 O'Donovan SM, Imami A, Eby H, Henkel ND, Creeden JF, Asah S, Zhang X, Wu X, Alnafisah R, Taylor RT, Reigle J, Thorman A, Shamsaei B, Meller J, McCullumsmith RE. Identification of candidate repurposable drugs to combat COVID-19 using a signature-based approach. Sci Rep 2021;11:4495. [PMID: 33627767 DOI: 10.1038/s41598-021-84044-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 13] [Article Influence: 7.0] [Reference Citation Analysis]
27 Booz GW, Zouein FA. Science unites a troubled world: Lessons from the pandemic. Eur J Pharmacol 2021;890:173696. [PMID: 33130278 DOI: 10.1016/j.ejphar.2020.173696] [Reference Citation Analysis]